Joining the Dots: Linking Disconnected Networks of Evidence Using Dose-Response Model-Based Network Meta-Analysis

Hugo Pedder, Sofia Dias, Meg Bennetts, Martin Boucher and Nicky J. Welton
Additional contact information
Hugo Pedder: Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Sofia Dias: Centre for Reviews and Dissemination, University of York, York, North Yorkshire, UK
Meg Bennetts: Pharmacometrics, Pfizer Ltd, Sandwich, Kent, UK
Martin Boucher: Pharmacometrics, Pfizer Ltd, Sandwich, Kent, UK
Nicky J. Welton: Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK

Medical Decision Making, 2021, vol. 41, issue 2, 194-208

Abstract: Background Network meta-analysis (NMA) synthesizes direct and indirect evidence on multiple treatments to estimate their relative effectiveness. However, comparisons between disconnected treatments are not possible without making strong assumptions. When studies including multiple doses of the same drug are available, model-based NMA (MBNMA) presents a novel solution to this problem by modeling a parametric dose-response relationship within an NMA framework. In this article, we illustrate several scenarios in which dose-response MBNMA can connect and strengthen evidence networks. Methods We created illustrative data sets by removing studies or treatments from an NMA of triptans for migraine relief. We fitted MBNMA models with different dose-response relationships. For connected networks, we compared MBNMA estimates with NMA estimates. For disconnected networks, we compared MBNMA estimates with NMA estimates from an “augmented†network connected by adding studies or treatments back into the data set. Results In connected networks, relative effect estimates from MBNMA were more precise than those from NMA models (ratio of posterior SDs NMA v. MBNMA: median = 1.13; range = 1.04–1.68). In disconnected networks, MBNMA provided estimates for all treatments where NMA could not and were consistent with NMA estimates from augmented networks for 15 of 18 data sets. In the remaining 3 of 18 data sets, a more complex dose-response relationship was required than could be fitted with the available evidence. Conclusions Where information on multiple doses is available, MBNMA can connect disconnected networks and increase precision while making less strong assumptions than alternative approaches. MBNMA relies on correct specification of the dose-response relationship, which requires sufficient data at different doses to allow reliable estimation. We recommend that systematic reviews for NMA search for and include evidence (including phase II trials) on multiple doses of agents where available.

Keywords: disconnected; dose; MBNMA; meta-analysis; network; NMA; synthesis (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X20983315 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:41:y:2021:i:2:p:194-208

DOI: 10.1177/0272989X20983315

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().